Posted by Michael Wonder on 06 Dec 2024
Molnupiravir for the treatment of patients with COVID-19 infection
26 November 2024 - NICE has published further draft guidance on the use of molnupiravir (Lagevrio) in the NHS in England.
For the time being, molnupiravir is not recommended for the treatment of adults with mild to moderate COVID-19 infection who have a positive SARS-CoV-2 test and one or more risk factors for developing severe COVID-19 disease.
